Effect of antioxidant in endothelial cells exposed to oxidized low-density lipoproteins.
Antioxidants such as probucol and alpha-tocopherol have been shown to attenuate the oxidation of low-density lipoproteins (LDL) and atherosclerotic lesions in animal models of atherosclerosis. The purpose of this study is to determine the protection effect of antioxidants on endothelial cells when exposed to oxidized and native LDL. In a cell-free system, we found that probucol, alpha-tocopherol, and ascorbic acid inhibited copper-induced LDL oxidation by a dose-dependent fashion (from 1 microM to 10 mM). In porcine aortic endothelial cells, antioxidants alone did not change basal endothelin-1 (ET-1) secretion. When porcine aortic endothelial cells were exposed to LDL and oxidized-LDL, both of them stimulated ET-1 secretion dose-dependently, whereas oxidized-LDL elicited higher ET-1 secretion. However, probucol, alpha-tocopherol, and ascorbic acid did not prevent LDL or oxidized-LDL induced ET-1 secretion. Furthermore, nimodipine inhibited both of native and oxidized LDL induced ET-1 secretion. Since Ca2+ channel blocker reduced the elevation of induced ET-1 secretion, the [Ca2+]i is possibly involved for the regulation of ET-1 secretion. Our results suggest that antioxidants can only prevent the oxidation of LDL rather than oxidized and native LDL-induced ET-1 secretion in vascular endothelial cells. The increase in the [Ca2+]i of endothelial cells through the opening of voltage-dependent Ca2+ channels may be involved in the LDL-induced ET-1 release.
Chen
T H
TH
Cardiovascular Research Center, Department of Comparative Medicine, Pig Research Institute Taiwan, Miaoli, ROC.
Tseng
H P
HP
Yang
J Y
JY
Mao
S J
SJ
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D001011:Aorta / Q000187:drug effects / Q000502:physiology; D002474:Cell-Free System; D004305:Dose-Response Relationship, Drug; D019332:Endothelin-1 / Q000187:drug effects* / Q000378:metabolism; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000378:metabolism; D008077:Lipoproteins, LDL / Q000378:metabolism / Q000494:pharmacology*; D008315:Malondialdehyde / Q000378:metabolism; D009553:Nimodipine / Q000494:pharmacology; D010084:Oxidation-Reduction; D013552:Swine; D014665:Vasodilator Agents / Q000494:pharmacology
D000975:Antioxidants; D019332:Endothelin-1; D008077:Lipoproteins, LDL; D014665:Vasodilator Agents; D008315:Malondialdehyde; D009553:Nimodipine